ArticleDrug design, development and therapy2020

Analysis of the Doxorubicin and Doxorubicinol in the Plasma of Breast Cancer Patients for Monitoring the Toxicity of Doxorubicin.

Yahdiana Harahap et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.